MdmX protects p53 from Mdm2-mediated degradation

Molecular and Cellular Biology

Volumn 20, Issue 3, 2000, Pages 1001-1007

  Jackson, Mark W ^a   Berberich, Steven J ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN INTERACTION; STRESS; TRANSACTIVATION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL NUCLEUS; GENES, P53; HELA CELLS; HUMANS; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE DELETION; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033963335     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.3.1001-1007.2000     Document Type: Article

References (35)

1. Amundson, S. A., T. G. Myers, and A. J. Fornace, Jr. 1998. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17:3287-3299.
2. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461-468.
3. Berberich, S. J., V. Litteral, L. D. Mayo, D. Tabesh, and D. Morris. 1999. mdm-2 gene amplification in 3T3-L1 preadipocytes. Differentiation 64:205-212.
4. Bottger, A., V. Bottger, A. Sparks, W. L. Liu, S. F. Howard, and D. P. Lane. 1997. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr. Biol. 7:860-869.
5. Bottger, V., A. Bottger, C. Garcia-Echeverria, Y. F. M. Ramos, A. J. van der Eb, A. G. Jochemsen, and D. P. Lane. 1999. Comparative study of the p53-mdm2 and p53-MDMX interfaces. Oncogene 18:189-199.
6. Cahilly-Snyder, L., T. Yang-Feng, U. Francke, and D. L. George. 1987. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat. Cell Mol. Genet. 13:235-244.
7. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and V. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-835.
8. Finlay, C. A. 1993. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13:301-306.
9. Freedman, D. A., L. Wu, and A. J. Levine. 1999. Functions of the MDM2 oncoprotein. Cell Mol. Life Sci. 55:96-107.
10. Haupt, Y., R. Maya, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296.
11. Hermeking, H., C. Lengauer, K. Polyak, T. C. He, L. Zhang, S. Thiagalingam, K. W. Kinzler, and B. Vogelstein. 1997. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1:3-11.
12. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27.
13. Hsieh, J. K., F. S. Chan, D. J. O'Connor, S. Mittnacht, S. Zhong, and X. Lu. 1999. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell 3:181-193.
14. Jackson, M., and S. J. Berberich. 1999. Constitutive mdmx expression during cell growth, differentiation and DNA damage. DNA Cell Biol. 18:695-700.
15. Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
16. Kubbutat, M. H. G., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299.
17. Kubbutat, M. H. G., R. L. Ludwig, M. Ashcroft, and K. H. Vousden. 1998. Regulation of Mdm2-directed degradation by the C terminus of p53. Mol. Cell. Biol. 18:5680-5698.
18. Kubbutat, M. H. G., R. L. Ludwig, A. J. Lerine, and K. H. Vousden. 1999. Analysis of the degradation function of Mdm2. Cell Growth Differ. 10:87-92.
19. Mayo, L. D., and S. J. Berberich. 1996. Wild type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation. Oncogene 13:2315-2321.
20. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
21. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
22. Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
23. Mosner, J., and W. Deppert. 1994. p53 and mdm2 are expressed independently during cellular proliferation. Oncogene 9:3321-3328.
24. Oliner, J. D., J. A Peitenol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Voglestein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860.
25. Polyak, K., Y. Xia, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300.
26. Pomerantz, J., N. Schreiber-Agus, N. J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, H. W. Lee, C. Cordon-Cardo, and R. A. DePinho. 1998. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713-723.
27. Roth, J., M. Dobbelstein, D. A. Freedman, T. Shenk, and A. J. Levine. 1998. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17:554-564.
28. Shvarts, A., M. Bazuine, P. Dekker, Y. F. M. Ramos, W. T. Steegenga, G. Merckx, R. C. A. van Ham, W. van der Houven van Oordt, A. J. van der Eb, and A. G. Jochemsen. 1997. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics 43:34.
29. Shvarts, A. S., T. Wilma, N. Riteco, T. van Laar, P. Dekker, M. Bazuine, R. C. A. van Ham, W. van der Houven van Oordt, G. Hateboer, A. J. van der Eb, and A. G. Jochemsen. 1996. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15:5349-5357.
30. Sigalas, I., A. H. Calvert, J. J. Anerson, D. E. Neal, and J. Lunec. 1996. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat. Med. 2:912-917.
31. Stommel, J. M., N. D. Marchenko, G. S. Jimenez, U. M. Moll, T. J. Hope, and G. M. Wahl. 1999. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18:1660-1672.
32. Tanimura, S., S. Ohtsuka, K. Mitsui, K. Shirouzu, A. Yoshimura, and M. Ohtsubo. 1999. MDM2 interacts with MDMX through their RING ringer domains. FEBS Lett. 447:5-9.
33. Tao, W., and A. J. Levine. 1999. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. USA 96:3077-3080.
34. Wu, G. S., T. F. Burns, E. R. McDonald III, W. Jiang, R. Meng, I. D. Krantz, G. Kao, D. D. Gan, J. Y. Zhou, R. Muschel, S. R. Hamilton, N. B. Spinner, S. Markowitz, G. Wu, and W. S. el-Deiry. 1997. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17:141-143.
35. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.